EUVIMEDEUVIMED entdecken
Crossref

NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma

Xueyang Fang, Rui Gong, Decai Yang, Chenxi Li, Yuanyuan Zhang, Yan Wang, Guohui Nie, Mingle Li iD, Xiaojun Peng iD, Bin Zhang iD

Journal of the American Chemical Society · 05.06.2024 · 146 (22) · 15251-15263

DOI: 10.1021/jacs.4c02530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 23.05.2024. Verfasst von Xueyang Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen Unive…. Hauptthemen laut MEDLINE: Glioblastoma, Infrared Rays, Exosomes, Phototherapy. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Basic and Applied Basic Research Foundation of Guangdong Province, Sanming Project of Medicine in Shenzen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) poses a significant therapeutic challenge due to its invasive nature and limited drug penetration through the blood-brain barrier (BBB). In response, here we present an innovative biomimetic approach involving the development of genetically engineered exosome nanocatalysts (Mn@Bi2Se3@RGE-Exos) for efficient GBM therapy via improving the BBB penetration and enzyme-like catalytic activities. Interestingly, a photothermally activatable multiple enzyme-like reactivity is observed in such a nanosystem. Upon NIR-II light irradiation, Mn@Bi2Se3@RGE-Exos are capable of converting hydrogen peroxide into hydroxyl radicals, oxygen, and superoxide radicals, providing a peroxidase (POD), oxidase (OXD), and catalase (CAT)-like nanocatalytic cascade. This consequently leads to strong oxidative stresses to damage GBM cells. In vitro, in vivo, and proteomic analysis further reveal the potential of Mn@Bi2Se3@RGE-Exos for the disruption of cellular homeostasis, enhancement of immunological response, and the induction of cancer cell ferroptosis, showcasing a great promise in anticancer efficacy against GBM with a favorable biosafety profile. Overall, the success of this study provides a feasible strategy for future design and clinical study of stimuli-responsive nanocatalytic medicine, especially in the context of challenging brain cancers like GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaInfrared RaysExosomesPhototherapyHumansAnimalsMiceCatalysisCell Line, TumorBrain NeoplasmsAntineoplastic AgentsManganeseBlood-Brain Barrier

Substanzen

Antineoplastic AgentsManganese

Autor:innen und Institutionen

  • Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen University Medical School, College of Materials Science and Engineering, Sh…
  • Faculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Uni…
  • State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China.

ORCID-Profile: Mingle Li, Xiaojun Peng, Bin Zhang

Förderung

  • Science and Technology Foundation of Shenzhen City
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Sanming Project of Medicine in Shenzen Municipality
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • National Natural Science Foundation of China
  • Shenzhen University
  • Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone

Zitieren

APA

Fang, X., Gong, R., Yang, D., Li, C., Zhang, Y., Wang, Y., Nie, G., Li, M., Peng, X., & Zhang, B. (2024). NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. Journal of the American Chemical Society, 146(22), 15251-15263. https://doi.org/10.1021/jacs.4c02530

Vancouver

Fang X, Gong R, Yang D, Li C, Zhang Y, Wang Y, et al. NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. Journal of the American Chemical Society. 2024;146(22):15251-15263. doi:10.1021/jacs.4c02530

BibTeX
@article{Fang2024,
  author = {Fang, Xueyang and Gong, Rui and Yang, Decai and Li, Chenxi and Zhang, Yuanyuan and Wang, Yan and Nie, Guohui and Li, Mingle and Peng, Xiaojun and Zhang, Bin},
  title = {NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  volume = {146},
  number = {22},
  pages = {15251--15263},
  doi = {10.1021/jacs.4c02530}
}
Kostenlos starten →